M

MannKind Corp

D
MNKD
USD
0.045
(0.6747%)
Market Closed
66,537.00
Volume
0.08
EPS
-
Div Yield
134.300
P/E
1,846,591,673.46
Market Cap
Today
0.6747%
1 Week
8.481%
1 Month
25.631%
6 Months
43.636%
12 Months
58.186%
Year To Date
84.225%
All Time
0%
News

Treasury Yields Decline as Market Anticipates Fed Rate Cuts

26.08.2024
Economy news

Novo Nordisk Surges in Profit and Sales

02.05.2024
Stocks news
More
Related Instruments
AAPL
AAPL
8.11
(3.6747%)
USD
AMZN
AMZN
3.45
(1.8508%)
USD
GILD
GILD
0.015
(0.0179%)
USD
MRK
MRK
-1.44
(-1.2137%)
USD
PFE
PFE
-0.09
(-0.3025%)
USD
ABT
ABT
-0.73
(-0.6354%)
USD
JNJ
JNJ
-1.31
(-0.7883%)
USD
ABBV
ABBV
0.73
(0.3784%)
USD
BMY
BMY
-0.72
(-1.4475%)
USD
SNY
SNY
0.8
(1.392%)
USD

Title:
MannKind Corp

Sector:
Healthcare
Industry:
Biotechnology
MannKind Corp is a biopharmaceutical company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. Its approved product, Afrezza (insulin human) Inhalation Powder, is an ultra-rapid-acting inhaled insulin used to improve glycemic control in adults with diabetes. The product consists of a dry powder formulation of human insulin delivered from a small portable inhaler.
Do you need help or have a question?
Contact Us